Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deerfield Management
Biotech
Ray shines a light on $125M round targeting genetic eye therapy
Ray Therapeutics has announced the closing of a $125 million series B financing to support candidates for patients with retinal degeneration.
Will Maddox
Apr 21, 2026 10:33am
Deerfield unveils $600M healthcare fund
May 5, 2025 10:26am
Deerfield suit says Alcon committed 'Valentine's Day massacre'
Feb 24, 2025 5:20pm
Cell therapy biotech Aurion joins IPO surge
Jan 27, 2025 2:42pm
AbbVie crafts $1.6B deal with molecular glue biotech Neomorph
Jan 23, 2025 9:58am
Novo Nordisk sticks down $1.46B in biobucks for molecular glues
Feb 26, 2024 2:50pm
